0.55 USD
↗ 0.02 (4.16%)PRE MARKET (AS OF 07:00 AM EDT)
Impact BioMedical, Inc. (IBO) trades at $0.55 per share. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9 and a bearish Death Cross on the long-term moving averages. Furthermore, IBO is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Sep 15, 2026.
Open?$0.53
High?$0.56
Low?$0.53
Prev. Close?$0.53
Volume?1.6K
Avg. Volume?200.2K
VWAP?$0.54
Rel. Volume?0.01x
Bid / Ask
Bid?$0.53 × 400
Ask?$0.45 × 7.5K
Spread?-$0.08
Midpoint?$0.49
Valuation & Ratios
Market Cap?57.1M
Shares Out?107.8M
Float?11.7M
Float %?10.9%
P/E Ratio?72.43
P/B Ratio?5.31
EPS?$0.01
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.
Themes
Employees
8
Market Cap
52.2M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2024-09-16
Address
1400 BROADFIELD BLVD.
HOUSTON, TX 77084
Phone: 585 232 1500
HOUSTON, TX 77084
Phone: 585 232 1500
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?71
Short Sent.?36
Piotroski F-Score?0/9Weak
Altman Z-Score?7.03Safe
Confidence?40%Low
Short InterestVery High
Short % of Float?4.59%Low
Short Interest?538.2K
Days to Cover?19.3
Free Float11.7M
Avg Daily Volume27.9K
Settlement Date2026-08-31
Financial Health
Current Ratio?0.16Weak
Quick Ratio?0.13Weak
Cash Ratio?0.00Low
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score53/100
P/E?72.4PRICEY▾
Peers100
S&P6
P/B?5.31FAIR▾
Peers100
S&P35
P/S?1,632.72HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-14.5CHEAP▾
S&P97
EV/Sales?1,632.44HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?7.3%FAIR▾
Peers50
S&P24
ROA?4.7%FAIR▾
Peers50
S&P43
Cash Flow & Enterprise
FCF?$-508000
Enterprise Value?$57.1M
Fundamentals ratios updated end of day